Nasopharyngeal Carriage Rate and Serotypes of Streptococcus pneumoniae and Antimicrobial Susceptibility in Healthy Korean Children Younger than 5 Years Old: Focus on Influence of Pneumococcal Conjugate Vaccination
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Even after pneumococcal vaccination introduction, Streptococcus pneumoniae (pneumoccocus) is still an important cause of respiratory and invasive severe infection. Pneumococcus is resided in nasal mucosa and local or systemic infection begins with the nasal mucosa damage. We studied the indirect effect of pneumococcal conjugate vaccine (PCV) on pneumococcal nasopharyngeal carriage rates, serotypes and antimicrobial susceptibility between vaccinate and non-vaccinated children. Materials and Methods: From January 2010 to October 2010, 379 healthy children under 5 years old from three university hospitals were recruited. Fully vaccinated children over 3 time doses of PCV and children with no vaccination history of PCV were enrolled, and nasopharyngeal aspirations were obtained from these children. Serotypes using multibead serotyping assay with multiplex PCR and antimicrobial susceptibility was analyzed. Antimicrobial susceptibilities were determined by the CLIS guideline. Results: Two hundred seventy six children were received pneumococcal vaccination while 103 were not. 137 pneumococci were isolated from nasopharyngeal aspiration specimens. Nasal carriage rate was significantly low in vaccinated group (P -value;0.001). Nasopharyngeal carriage rate was 28.6% (79/276) in vaccinate group and 56.3% (58/103) in non-vaccinated group. Among those vaccinated group, 13.0% (36/276) of the serotypes were vaccine or vaccine related type with the most common type 19F. In contrast, 31.1% (32/103) of the serotypes in non vaccinated group were vaccine or vaccine related type with the most common type 6A. The resistant rate of penicillin was 90.5%. For antimicrobial susceptibility, amoxicillin and amoxicillin/clavulanate showed high susceptibility (73.0%), but 19F and 19A serotypes were all resistant against amoxicillin. Conclusions: High nasopharyngeal carriage rate in non vaccinated group corresponded to the result of past study. However,19F and 19A still came up as problematic serotypes with a high carriage rate and antimicrobial resistance in both vaccinated and non vaccinated groups. Also, this study showed that the resistance rate of primary oral antimicrobial agents was increased in compared to past. For solving these problems, the selective antimicrobial use with establishment of high dose amoxicillin/clavulanate regimen and active PCV immunization should be needed. Furthermore, pneumococcal carriage and serotype study concerning with antimicrobial susceptibility should be conducted in the future in 10 or 13-valent PCV received children.
Abstract
Background: Even after pneumococcal vaccination introduction, Streptococcus pneumoniae (pneumoccocus) is still an important cause of respiratory and invasive severe infection. Pneumococcus is resided in nasal mucosa and local or systemic infection begins with the nasal mucosa damage. We studied the indirect effect of pneumococcal conjugate vaccine (PCV) on pneumococcal nasopharyngeal carriage rates, serotypes and antimicrobial susceptibility between vaccinate and non-vaccinated children. Materials and Methods: From January 2010 to October 2010, 379 healthy children under 5 years old from three university hospitals were recruited. Fully vaccinated children over 3 time doses of PCV and children with no vaccination history of PCV were enrolled, and nasopharyngeal aspirations were obtained from these children. Serotypes using multibead serotyping assay with multiplex PCR and antimicrobial susceptibility was analyzed. Antimicrobial susceptibilities were determined by the CLIS guideline. Results: Two hundred seventy six children were received pneumococcal vaccination while 103 were not. 137 pneumococci were isolated from nasopharyngeal aspiration specimens. Nasal carriage rate was significantly low in vaccinated group (P -value;0.001). Nasopharyngeal carriage rate was 28.6% (79/276) in vaccinate group and 56.3% (58/103) in non-vaccinated group. Among those vaccinated group, 13.0% (36/276) of the serotypes were vaccine or vaccine related type with the most common type 19F. In contrast, 31.1% (32/103) of the serotypes in non vaccinated group were vaccine or vaccine related type with the most common type 6A. The resistant rate of penicillin was 90.5%. For antimicrobial susceptibility, amoxicillin and amoxicillin/clavulanate showed high susceptibility (73.0%), but 19F and 19A serotypes were all resistant against amoxicillin. Conclusions: High nasopharyngeal carriage rate in non vaccinated group corresponded to the result of past study. However,19F and 19A still came up as problematic serotypes with a high carriage rate and antimicrobial resistance in both vaccinated and non vaccinated groups. Also, this study showed that the resistance rate of primary oral antimicrobial agents was increased in compared to past. For solving these problems, the selective antimicrobial use with establishment of high dose amoxicillin/clavulanate regimen and active PCV immunization should be needed. Furthermore, pneumococcal carriage and serotype study concerning with antimicrobial susceptibility should be conducted in the future in 10 or 13-valent PCV received children.
참고문헌 (28)
- Holmes SJ, "Child-care practices:effects of social change on the epidemiology of infectiousdiseases and antibiotic resistance", Epidemiol Rev, 18, pp.10~28 (1996)
- 김선미, "국내 소아의 비강 내 폐구균 보균율과 혈청형에 관한 역학연구", Korean Journal of Pediatrics, 47(6), pp.611~616 (2004), 대한소아과학회
- Kim KH, "Serogroup and antimicrobial resistanceof Streptococcus pneumoniae isolated from oropharynxin children attending day care center", J Korean PediatrSoc, 45, pp.346~353 (2002)
- 이진아, "소아의 임상 검체 및 건강한 소아의 비인두에서 분리된 페구균의 혈청형 및 페니실린 감수성", Korean Journal of Pediatrics, 46(9), pp.846~853 (2003), 대한소아과학회
- Mastro TD, "Use of nasopharyngeal isolates of Streptococcus pneumoniaeand Haemophilus influenzae from children in Pakistanfor surveillance for antimicrobial resistance", PediatrInfect Dis J, 12, pp.824~830 (1993)
- Klugman KP, "Drug resistance patterns andserogroups or serotypes of pneumococcal isolates fromcerebrospinal fluid or blood, 1979-1986", J Infect Dis, 158, pp.956~964 (1988)
- Soh SW, "Serotype distribution and antimicrobialresistance of Streptococcus pneumoniae isolatesfrom pediatric patients in Singapore", Antimicob AgentsChemother, 44, pp.2193~2196 (2000)
- Charpentier E, "Mechanisms of antibioticresistance and tolerance in Streptococcus pneumoniae", MicrobesInfect, 2, pp.1855~1864 (2000)
- "Trends in the antimicrobial susceptibility of bacterial respiratorytract pathogens--findings of the Alexander Project1992-1996", J Chemother, 11(1), pp.5~21 (1999)
- Finch R, "Bacterial resistance-the clinical challenge", Clin MicrobiolInfect, 8(3), pp.21~32 (2002)
- Cunha BA, "Penicillin resistance in pneumococcal pneumonia.Antibiotics with low resistance potential are effectiveand pose less risk", Postgrad Med, 113, pp.42~54 (2003)
- Yu J, "Carvalho Mda G, Beall B, Nahm MH. A rapid pneumococcalserotyping system based on monoclonal antibodiesand PCR", J Med Micobiol, 57, pp.171~178 (2008)
- Huang SS, "Continued impact of pneumococcal conjugatevaccine on carriage in young children", Pediatrics, 124, pp.e1~e11 (2009)
- 김경효, "Nasopharyngeal Pneumococcal Carriage of Children Attending Day Care Centers in Korea: Comparison between Children Immunized with 7-valent Pneumococcal Conjugate Vaccine and Non-immunized", Journal of Korean Medical Science, 26(2), pp.184~190 (2011), 대한의학회
- Craig WA, "Pharmacokinetic", pharmacodynamic parameters:rationale for antibacterial dosing of mice and men, 1998, pp.26, 1~10
- Jacobs MR, "Optimization of antimicrobial therapy usingpharmacokinetic and pharmacodynamic parameters", ClinMicrobiol Infect, 7, pp.589~596 (2001)
- Drusano GL, "Relevance of pharmacokinetics andpharmacodynamics in the selection of antibiotics for respiratorytract infections", J Chemother, 9(3), pp.38~44 (1997)
- Park JY, "Pharyngeal colonization rate of penicillinresistantStreptococcus pneumoniae among day care centerchildren in Seoul, Korea", Korean J Infect Dis, 31, pp.122~128 (1999)
- 강진한, "급성 호흡기감염 환아에서 분리된 폐구균에 대한 페니실린 내성분포와 경구 항생제에 대한 감수성 연구", Korean Journal of Pediatrics, 48(1), pp.40~47 (2005), 대한소아과학회
- Kang JH, "In vitro antimicrobialactivity of cefditoren and other oral antibiotics againstStreptococcus pneumoniae, isolated from children withcommunity acquired respiratory tract infections", Jpn J Antibiot, 63, pp.11~7 (2010)
- Ko KS, "Multidrug?resistant Streptococcuspneumoniae serotype 6D clones in South Korea", J Clin Microbiol, 50, pp.818~822 (2011)
- Clinical and Laboratory Standards Instit, "Streptococcuspneumoniae. In: Performance standards for antimicrobialsusceptibility testing; twentieth informational supplement.Document M100-S20. Wayne", PA: Clinical and LaboratoryStandards Institute, 88~91 (2010)
- Brandileone MC, "Geographic distributionof penicillin resistance of Streptococcus pneumoniae in Brazil:genetic relatedness", Microb Drug Resist, 4, pp.209~217 (1998)
- Gray BM, "Epidemiologicstudies of Streptococcus pneumoniae infants: acquisition,carriage, and infection during the first 24 months of life", Jinfect Dis, 142, pp.923~933 (1980)
- Dagan R, "Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life:relation to serotypes likely to be included in pneumococcalconjugate vaccines", J infect Dis, 174, pp.1352~1355 (1996)
- Jin P, "First report of putative Streptococcus pneumoniaeserotype 6D among nasopharyngeal isolates from Fijianchildren", J Infect Dis, 200, pp.1375~1380 (2009)
- Bratcher PE, "Identificationof natural pneumococcal isolates expressing serotype6D by genetic, biochemical and serological characterization", Microbiology, 156, pp.555~560 (2010)
- Doern GV, "Antimicrobial resistance of Streptococcus pneumoniaerecovered from outpatients in the United States duringthe winter months of 1994 to 1995: results of a 30-centernational surveillance study", Antimicrob Agents Chemother, 40, pp.1208~1213 (1996)